Clinical trial
A Double-blind Placebo-controlled Randomized Controlled Trial (RCT) of 3ml Methoxyflurane for Intrauterine Device (IUD) Insertion and Endometrial Biopsy
NCT07046572 is registered in ClinicalTrials.gov with Mount Sinai Hospital, Canada as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Double-blind Placebo-controlled Randomized Controlled Trial (RCT) of 3ml Methoxyflurane for Intrauterine Device (IUD) Insertion and Endometrial Biopsy
- Lead sponsor
- Mount Sinai Hospital, Canada
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- July 24, 2025
- Completion date
- March 1, 2026
- Enrollment
- 174 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
endometrial biopsy, intrauterine devices